BEAM
Price
$17.14
Change
+$0.38 (+2.27%)
Updated
Jun 26 closing price
Capitalization
1.72B
46 days until earnings call
KOD
Price
$3.78
Change
+$0.09 (+2.44%)
Updated
Jun 26 closing price
Capitalization
199.45M
52 days until earnings call
Interact to see
Advertisement

BEAM vs KOD

Header iconBEAM vs KOD Comparison
Open Charts BEAM vs KODBanner chart's image
Beam Therapeutics
Price$17.14
Change+$0.38 (+2.27%)
Volume$1.3M
Capitalization1.72B
Kodiak Sciences
Price$3.78
Change+$0.09 (+2.44%)
Volume$558.05K
Capitalization199.45M
BEAM vs KOD Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KOD commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and KOD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (BEAM: $17.14 vs. KOD: $3.78)
Brand notoriety: BEAM and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. KOD: 144%
Market capitalization -- BEAM: $1.72B vs. KOD: $199.45M
BEAM [@Biotechnology] is valued at $1.72B. KOD’s [@Biotechnology] market capitalization is $199.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, KOD is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while KOD’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • KOD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than KOD.

Price Growth

BEAM (@Biotechnology) experienced а +0.88% price change this week, while KOD (@Biotechnology) price change was +7.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

KOD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.72B) has a higher market cap than KOD($199M). BEAM YTD gains are higher at: -30.887 vs. KOD (-62.010). KOD has higher annual earnings (EBITDA): -162.44M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. KOD (139M). KOD has less debt than BEAM: KOD (67.6M) vs BEAM (158M). BEAM has higher revenues than KOD: BEAM (63.6M) vs KOD (0).
BEAMKODBEAM / KOD
Capitalization1.72B199M866%
EBITDA-399.03M-162.44M246%
Gain YTD-30.887-62.01050%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B139M878%
Total Debt158M67.6M234%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKOD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGMAX25.210.27
+1.08%
Janus Henderson Triton A
RCEYX58.30N/A
N/A
Victory RS Large Cap Alpha Y
FGRSX42.60N/A
N/A
Federated Hermes Intl Leaders R6
FSYKX10.03N/A
N/A
Fidelity Advisor Sustainable EM Eq C
VSFSX23.31N/A
N/A
Federated Hermes Clover Small Value R6

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.27%
CRSP - BEAM
72%
Closely correlated
-0.17%
RXRX - BEAM
64%
Loosely correlated
+4.65%
NTLA - BEAM
64%
Loosely correlated
+0.52%
SYRE - BEAM
58%
Loosely correlated
+3.96%
ABSI - BEAM
58%
Loosely correlated
-1.81%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+2.44%
XNCR - KOD
54%
Loosely correlated
-1.87%
NRIX - KOD
48%
Loosely correlated
+1.89%
COGT - KOD
48%
Loosely correlated
+3.68%
BEAM - KOD
48%
Loosely correlated
+2.27%
IDYA - KOD
46%
Loosely correlated
+1.27%
More